Transcription of BCLC stage C の進行肝細胞癌を ... - …
{{id}} {{{paragraph}}}
1 JSTHAECRG (Japan Society of Transcatheter Hepatic Arterial Embolization Clinical Research Group) JSTHAECRG-2013-01 (HCC-Sorafenib+TACEII) bclc stage C TACE II Phase II trial of Sorafenib combined with on-demand Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma (Barcelona Clinic Liver Cancer stage C): STAB study IVR IVR 464-8681 1-1 TEL 052-762-6111 FAX 052-764-2966 E-mail 2013 4 12 Version 2013 5 3 Version 2013 5 11 Version 2013 6 7 Version 2013 7 18 Version 2013 7 29 Version 2 0. bclc stage C (TACE) II bclc stage C TACE Primary endpoint: Secondary endpoints: 1) 2) 3) 4) 20 5) bclc - stage C Vp3, 4 6) 7) ECOG Performance Status 0 1 8) 9) Child-Pugh A score 5-6 10) 4 2 11) 8 12)
1 JSTHAECRG (Japan Society of Transcatheter Hepatic Arterial Embolization Clinical Research Group) JSTHAECRG-2013-01 (HCC-Sorafenib+TACEⅡ) BCLC stage C の進行肝細胞癌を対象とした
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}